NFATC3 and cardiac hypertrophy: Unlike other prohypertrophic signaling pathways, the calcineurin/NFATc3 pathway participates in pathological, but not physiological, cardiac hypertrophy (38, 44, 56); thus, it may manifest more important significance in CKD-induced LVH.